CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...
Phase 2
Rome, Italy and 39 other locations
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...
Phase 2, Phase 3
Roma, Italy and 89 other locations
versus (vs) placebo on the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) up to Week 80 in study participants with prodromal or mild Alzheimer's...
Phase 2
Rome, Italy and 102 other locations
be from 2 clinical subgroups: mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild Alzheimer's disease...
Phase 2
Roma, Italy and 168 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Roma, Italy and 246 other locations
The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (inclu...
Phase 2
Roma, Lazio, Italy and 103 other locations
A long-term extension study to evaluate the safety, tolerability, and efficacy of AL002 in participants with Early Alzheimer's Disease...
Phase 2
Rome, Lazio, Italy and 53 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Roma, Italy and 99 other locations
outpatient study in subjects with psychosis associated with Alzheimer's Disease.The primary objective of the study is to evaluate r ...
Phase 3
Roma, Italy and 106 other locations
the immune system and other biological processes in people with Alzheimer's disease. Semaglutide is a medicine that doctors can pre...
Phase 3
Roma, Italy and 9 other locations
Clinical trials
Research sites
Resources
Legal